| Optimizing ceftolozane-tazobactam dosage in critically ill patients during continuous venovenous hemodiafiltration G Aguilar, R Ferriols, S Martínez-Castro, C Ezquer, E Pastor, JA Carbonell, ... Critical Care 23, 1-3, 2019 | 24 | 2019 |
| Pharmacokinetics of anidulafungin during venovenous extracorporeal membrane oxygenation G Aguilar, R Ferriols, JA Carbonell, C Ezquer, JM Alonso, A Villena, ... Critical Care 20, 1-2, 2016 | 22 | 2016 |
| Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous … A Pérez-Pitarch, R Ferriols-Lisart, G Aguilar, C Ezquer-Garín, FJ Belda, ... International Journal of Antimicrobial Agents 51 (1), 115-121, 2018 | 18 | 2018 |
| Optimal doses of caspofungin during continuous venovenous hemodiafiltration in critically ill patients G Aguilar, R Ferriols, A Lozano, C Ezquer, JA Carbonell, A Jurado, ... Critical Care 21, 1-3, 2017 | 16 | 2017 |
| Stability of tacrolimus ophthalmic solution C Ezquer-Garin, R Ferriols-Lisart, M Alós-Almiñana American Journal of Health-System Pharmacy 74 (13), 1002-1006, 2017 | 16 | 2017 |
| Fit-for-purpose chromatographic method for the determination of amikacin in human plasma for the dosage control of patients C Ezquer-Garin, L Escuder-Gilabert, Y Martín-Biosca, RF Lisart, ... Talanta 150, 510-515, 2016 | 14 | 2016 |
| Validated HPLC-UV detection method for the simultaneous determination of ceftolozane and tazobactam in human plasma C Ezquer-Garin, R Ferriols-Lisart, M Alós-Almiñana, G Aguilar-Aguilar, ... Bioanalysis 10 (7), 461-473, 2018 | 12 | 2018 |
| Ceftolozane pharmacokinetics in a septic critically ill patient under different extracorporeal replacement therapies N Carbonell, G Aguilar, R Ferriols, R Huerta, J Ferreres, M Calabuig, ... Antimicrobial agents and chemotherapy 64 (1), 10.1128/aac. 01782-19, 2019 | 8 | 2019 |
| Pharmacokinetic/Pharmacodynamic analysis of voriconazole against Candida spp. and Aspergillus spp. in allogeneic stem cell transplant recipients A Perez-Pitarch, B Guglieri-Lopez, R Ferriols-Lisart, A Pérez, ... Therapeutic Drug Monitoring 41 (6), 740-747, 2019 | 8 | 2019 |
| Plasma concentrations of caspofungin in a critically ill patient with morbid obesity R Ferriols-Lisart, G Aguilar, A Pérez-Pitarch, J Puig, C Ezquer-Garín, ... Critical Care 21 (1), 200, 2017 | 8 | 2017 |
| Stability of tedizolid phosphate-sodium rifampicin and tedizolid phosphate-meropenem admixtures in intravenous infusion bags stored at different temperatures C Ezquer-Garin, R Ferriols-Lisart, LM Martinez-López, ... Die Pharmazie-An International Journal of Pharmaceutical Sciences 75 (5 …, 2020 | 5 | 2020 |
| Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances G Aguilar, R Ferriols, S Martínez-Castro, C Ezquer, E Pastor, JA Carbonell, ... Critical Care 24, 1-2, 2020 | 4 | 2020 |
| Stability of mycophenolate mofetil in polypropylene 5% dextrose infusion bags and chemical compatibility associated with the use of the Equashield® closed … C Ezquer‐Garin, R Ferriols‐Lisart, M Alós‐Almiñana Biomedical Chromatography 33 (7), e4529, 2019 | 1 | 2019 |
| Validated HPLC‐UV method for amphotericin B quantification in a critical patient receiving AmBisome and treated with extracorporeal replacement therapies C Ezquer‐Garin, G Aguilar, R Ferriols‐Lisart, M Alos‐Almiñana Biomedical Chromatography 37 (12), e5749, 2023 | | 2023 |
| Desarrollo y validación de métodos cromatográficos ajustados a propósito para la monitorización de antimicrobianos de interés clínico. Aplicación a estudios farmacocinéticos C Ezquer Garin Desarrollo y validación de métodos cromatográficos ajustados a propósito …, 2023 | | 2023 |
